RankingsPricing
  1. US-listed companies
  2. IONIS PHARMACEUTICALS INC
  3. Financials
  4. Provision for income taxes

IONIS PHARMACEUTICALS INCIONS

Market cap
$12.9B
P/E ratio
SummaryFinancials
Period EndProvision for income taxes (Million USD)YoY (%)
Dec 31, 2024-6-119.09%
Dec 31, 202332+175.38%
Dec 31, 202212-2230.13%
Dec 31, 2021-1-100.17%
Dec 31, 2020317+628.01%
Dec 31, 201944-114.94%
Dec 31, 2018-291+4768.58%
Dec 31, 2017-6-303.82%
Dec 31, 20163+688.71%
Dec 31, 20150-102.41%
Dec 31, 2014-15-140163.64%
Dec 31, 20110-88.04%
Dec 31, 20100

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)